Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP Registry real-world cohort (AIO-TRK-0315)
Journal article published in 2021 by
F. Griesinger,
M. Sebastian,
W. Brueckl,
H.-D. Hummel,
B. Jaeschke,
J. Kern,
C. Schumann,
C. Wesseler 
,
M. Jaenicke,
A. Fleitz,
S. Zacharias,
A. Hipper,
A. Groth,
W. Weichert,
S. Doerfel
and other authors.
,
M. Jaenicke,
A. Fleitz,
S. Zacharias,
A. Hipper,
A. Groth,
W. Weichert,
S. Doerfel
and other authors.
